Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Rasburicase (Fasturtec)].

B Vogt1, M Gugger, F J Frey

  • 1Klinik und Poliklinik für Nephrologie und Hypertonie, Universitätsspital Bern, Inselspital, Bern. bruno.vogt@insel.ch

Therapeutische Umschau. Revue Therapeutique
|October 21, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sprengel deformity: What is the functional outcome of conservative treatment versus surgical correction?

Orphanet journal of rare diseases·2025
Same author

Distribution of regional lung function in upright healthy subjects determined by electrical impedance tomography in two chest examination planes.

Physiological measurement·2023
Same author

[Growth modulation through hemiepiphysiodesis : Novel surgical techniques: risks and progress].

Der Orthopade·2021
Same author

Identification and analysis of stable breathing periods in electrical impedance tomography recordings.

Physiological measurement·2021
Same author

Fibula-Assisted Segment Transport (FAST) for Defect Reconstruction after Resection of Tibial Adamantinoma: Report of Two Treatments.

Case reports in orthopedics·2021
Same author

Regional lung function measures determined by electrical impedance tomography during repetitive ventilation manoeuvres in patients with COPD.

Physiological measurement·2021
Same journal

[Multimodal Cardiac Imaging: New Developments for Clinical Practice].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Coronary angiography: From cardiac catheterization to advanced interventional cardiovascular imaging].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Athlete's heart: role of cardiac imaging in the prevention of sudden cardiac death].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Multimodal imaging in cardiac amyloidosis and cardiac sarcoidosis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Inflammatory Heart Disease: The Role of Multimodality Cardiac Imaging in Myocarditis and Pericarditis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

State-of-the-Art Cardiac Imaging

Therapeutische Umschau. Revue therapeutique·2026
See all related articles

Rasburicase is an enzyme that rapidly lowers high uric acid levels, offering a faster treatment for tumor lysis syndrome and severe gout compared to allopurinol.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Nephrology

Background:

  • Hyperuricemia, characterized by elevated serum uric acid, is a critical condition.
  • Tumor lysis syndrome (TLS) and severe gout with tophi formation are major causes of hyperuricemia.
  • Current treatments like allopurinol may not provide rapid enough control for severe cases.

Purpose of the Study:

  • To evaluate rasburicase as a rapid-acting therapeutic agent for managing hyperuricemia.
  • To compare the efficacy of rasburicase with existing treatments, such as allopurinol.
  • To assess the role of rasburicase in specific clinical scenarios like TLS and severe gout.

Main Methods:

  • Rasburicase is an enzyme that catalyzes the conversion of uric acid to allantoin.
  • Allantoin is a more water-soluble metabolite readily excreted by the kidneys.

Related Experiment Videos

  • Clinical studies assess serum uric acid reduction and renal function improvement.

    • Main Results:

    • Rasburicase demonstrates a more rapid control of serum uric acid levels compared to allopurinol.
    • Effective in lowering uric acid concentrations in patients with tumor lysis syndrome.
    • Leads to secondary improvement in renal function in TLS patients.
    • Shows promise in managing severe tophaceous gout by controlling serum uric acid.

    Conclusions:

    • Rasburicase addresses an unmet clinical need for rapid hyperuricemia management.
    • It is a valuable therapeutic option for tumor lysis syndrome and severe gout.
    • Offers a faster and effective alternative to traditional treatments for controlling uric acid levels.